Avantor Investor Day Presentation Deck
3. BIOPRODUCTION
Unique position in Biopharma production
Represents 35% of total Biopharma revenue¹
CUSTOMIZED MATERIALS
Creating customized materials
for use in highly regulated,
demanding applications
Navantor™
Solutions
specified in
80%
OF TOP 20
biologic drugs
Formulation
product line covers
95%
of
EXCIPIENTS
used in commercial
mAbs
Delivering
~75%
PROPRIETARY
MATERIALS
Servicing a
~$13B
TAM²
Delivering
through
5
Innovation centers
of excellence
1. Based on FY21 estimate, excluding pending M&A
2. TAM Total Addressable Market. Market size per company estimates
Global network of
CGMP manufacturing
and ISO-certified
distribution
facilities on
3
CONTINENTS
Buffers
product line covers
100%
of traditional
BUFFERS
PACKAGES
Bioproduction
materials
Chemicals,
reagents, serum
Single-use
solutions
Assemblies,
components & fluid
transfer solutions
Bioproduction
services
Downstream process
optimization
27View entire presentation